Microflora imbalance and gastrointestinal diseases

Digestive and Liver Disease Supplements

Volumn 3, Issue 2, 2009, Pages 35-39

  Ojetti, V ^a   Gigante, G ^a   Ainora, M E ^a   Fiore, F ^a   Barbaro, F ^a   Gasbarrini, A ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Inflammation; Intestinal disorders; Intestinal microflora

Indexed keywords

BILE ACID;

ACTINOBACTERIA; ARTICLE; BACTERIAL STRAIN; BACTEROIDETES; CELIAC DISEASE; COLON CANCER; COLONY FORMING UNIT; DIVERTICULOSIS; ENTERITIS; FIRMICUTES; HUMAN; IMMUNE RESPONSE; INTESTINE FLORA; INTESTINE MOTILITY; IRRITABLE COLON; NONHUMAN; PATHOGENESIS; PH; PRIORITY JOURNAL; PROTEOBACTERIA; TEMPERATURE;

EID: 67650391665     PISSN: 15945804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1594-5804(09)60017-6     Document Type: Article

References (46)

1. Berg R. The indigenous gastrointestinal microflora. Trends Microbiol 4 (1996) 430-435
2. Drasar B.S., Shiner M., and Mcloed G.M. Studies on the intestinal flora. The bacterial flora of ther gastrointestinal tract in healthy and achlorhydric persons. Gastroenterology 56 (1969) 71-79
3. Simon G.L., and Gorbach S.L. Intestinal flora in health and disease. Gastroenterology 86 (1984) 174-193
4. Balfour Sartor R. Microbial influences in Inflammatory Bowel Disease. Gastroenterology 134 (2008) 577-594
5. Falk P.G., Hooper L.V., Midtvedt T., et al. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev 62 (1998) 1157-1170
6. Podolsky D.K. Inflammatory bowel disease. N Engl J Med 347 (2002) 417-429
7. Sartor R.B. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126 (2004) 1620-1633
8. Mahida Y.R., and Rolfe V.E. Host-bacterial interactions in inflammatory bowel disease. Clin Sci (London) 107 (2004) 331-341
9. Kullberg M.C., Ward J.M., Gorelick P.L., et al. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12-and gamma-interferon-dependent mechanism. Infect Immun 66 (1998) 5157-5166
10. van Nuenen M., Venema K., van der Woude J., et al. The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease. Dig Dis Sci 49 (2004) 485-491
11. Niess J.H., Brand S., Gu X., et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307 (2005) 254-258
12. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu Rev Immunol 21 (2003) 335-376
13. Sirard J.C., Bayardo M., and Didierlaurent A. Pathogen-specific TLR signaling in mucosa: mutual contribution of microbial TLR agonists and virulence factors. Eur J Immunol 36 (2006) 260-263
14. O'Neill L.A. How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 18 (2006) 3-9
15. King T.S., Elia M., and Hunter J.O. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 352 (1998) 1187-1189
16. Floch M.H. Bile salts, intestinal microflora and enterohepatic circulation. Dig Liver Dis 34 Suppl 2 (2002) S54-S57
17. Barbara G., De Giorgio R., Stanghellini V., et al. A role for inflammation in irritable bowel syndrome?. Gut 51 Suppl 1 (2002) i41-i44
18. Barbara G., Stanghellini V., De Giorgio R., et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126 (2004) 693-702
19. Balsari A., Ceccarelli A., Dubini F., et al. The fecal microbial population in the irritable bowel syndrome. Microbiologica 5 (1982) 185-194
20. Mättö J., Maunuksela L., Kajander K., et al. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome - a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 43 (2005) 213-222
21. Wyatt G.M., Bayliss C.E., Lakey A.F., et al. The faecal flora of two patients with food-related irritable bowel syndrome during challenge with symptom-provoking foods. J Med Microbiol 26 (1988) 295-299
22. Pimentel M., Mayer A.G., Park S., et al. Methane production during lactulose breath test is associated with gastrointestinal disease presentation. Dig Dis Sci 48 (2003) 86-92
23. Pimentel M., Kong Y., and Park S. IBS subjects with methane on lactulose breath test have lower postprandial serotonin levels than subjects with hydrogen. Dig Dis Sci 49 (2004) 84-87
24. Halpern G.M., Prindiville T., Blankenburg M., et al. Treatment of irritable bowel syndrome with Lacteol Fort: A randomized, doubleblind, cross-over trial. Am J Gastroenterol 91 (1996) 1579-1585
25. O'Mahony L., McCarthy J., Kelly P., et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles. Gastroenterology 128 (2005) 541-551
26. Guarner F., and Malagelada J.R. Gut flora in health and disease. Lancet 361 (2003) 512-519
27. Niedzielin K., Kordecki H., and Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 13 (2001) 1143-1147
28. Kim H.J., Camilleri M., McKinzie S., et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 17 (2003) 895-904
29. Cianci R., Iacopini F., Petruzziello L., et al. Involvement of central immunity in uncomplicated diverticular disease. Scand J Gastroenterol 44 (2009) 108-115
30. Latella G., Pimpo M.T., Sottili S., et al. Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis 18 (2003) 55-62
31. D'Incà R., Pomerri F., Vettorato M.G., et al. Interaction between rifaximin and dietary fibre in patients with diverticular disease. Aliment Pharmacol Ther 25 (2007) 771-779
32. Colecchia A., Vestito A., Pasqui F., et al. Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease. World J Gastroenterol 13 (2007) 264-269
33. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 119 (2000) 234-242
34. Stenhammar L., Fälth-Magnusson K., Jansson G., et al. Intestinal permeability to inert sugars and different-sized polyethyleneglycols in children with celiac disease. J Pediatr Gastroenterol Nutr 9 (1989) 281-289
35. Kagnoff M.F., Austin R.K., Hubert J.J., et al. Possible role for a human adenovirus in the pathogenesis of coeliac disease. J Exp Med 160 (1984) 1544-1557
36. Lahdeaho M.L., Parkkonen P., Reunala T., et al. Antibodies to E1b protein-derived peptides of enteric adenovirus type 40 are associated with celiac disease and dermatitis herpetiformis. Clin Immunol Immunopathol 69 (1993) 300-305
37. Ivarsson A., Hernell O., Nystrom L., et al. Children born in the summer have an increased risk for coeliac disease. J Epidemiol Community Health 57 (2003) 36-39
38. Ivarsson A., Persson L.A., Nyström L., et al. The epidemic of coeliac disease in Swedish children. Acta Paediatr 89 (2000) 165-171
39. Forsberg G., Fahlgren A., Hörstedt P., et al. Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease. Am J Gastroenterol 99 (2004) 894-904
40. Tjellström B., Stenhammar L., Högberg L., et al. Gut microflora associated characteristics in children with celiac disease. Scand J Gastroenterol 42 (2007) 1204-1208
41. Freitas M., Axelsson L.-G., Cayuela C., et al. Indigenous microbes and their soluble factors differentially modulate intestinal glycosylation steps in vivo. Use of a "lectin assay" to survey in vivo glycosylation changes. Histochem Cell Biol. 124 (2005) 423-433
42. Uibo O., Uibo R., Kleimola V., et al. Serum IgA antigliadin antibodies in an adult population sample. High prevalence without celiac disease. Dig Dis Sci 38 (1993) 2034-2037
43. Sepp E., Julge K., Vasar M., et al. Intestinal microflora of Estonian and Swedish infants. Acta Paediatr 86 (1997) 956-961
44. Schuppan D., and Hahn E.G. Gluten and the gut - Lessons for immune regulation. Science 297 (2002) 2218-2220
45. Shan L., Molberg Ø., Parrot I., et al. Structural basis for gluten intolerance in celiac sprue. Science 297 (2002) 2275-2279
46. Guarner F., and Malagelada J. Gut in health and disease. The Lancet (2003 Feb) 360